Dr Reddy's lines up Rs 1,000 crore capex for current fiscal year SECTIONS Last Updated: May 24, 2021, 01:04 PM IST Share Agencies The company remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official. INSIGHTS NSE Explore Now NEW DELHI: Drug major Dr Reddy's Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official. The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal. "The Capex will be around the same numbers, maybe a bit higher if everything goes through," Dr Reddy's Laboratories CEO Erez Israeli said in an analyst call.